Rigel Pharmaceuticals: Behind The Huge Rally
Source: SeekingAlpha
2025-11-25 18:01:00 ET
Shares of hematologic and oncology concern Rigel Pharmaceuticals, Inc. ( RIGL ) have moved up sharply over the past month. The rally is being propelled by much better than expected Q3 results that posted earlier in this month. All three of its commercial assets demonstrated stronger than expected performance with top seller Tavalisse the beneficiary of coverage gap eliminations from the Inflation Reduction Act. Can the rally continue? An analysis follows below....
Read the full article on Seeking Alpha
For further details see:
Rigel Pharmaceuticals: Behind The Huge Rally
Rigel Pharmaceuticals Inc.
NASDAQ: RIGL
RIGL Trading
-3.13% G/L:
$26.0825 Last:
96,605 Volume:
$26.87 Open:
RIGL Latest News
March 03, 2026 04:01:00 pm
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
RIGL Stock Data
$625,132,287
16,430,597
0.07%
54
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
